Showing results (71-80 of 163) with videos related to
Sort By:
Pageof 17
Vaccine|April 23, 2016
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptidesAnn J Hessell, Sean McBurney, Shilpi Pandey, et al.Virology|December 10, 2013
Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 maskingAidy Salomon, Chavdar Krachmarov, Zhong Lai, et al.Journal of Virology|October 7, 2016
Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in RabbitsXunqing Jiang, Max Totrov, Wei Li, et al.Plos One|March 20, 2012
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradicationEkaterina Dadachova, Scott G Kitchen, Gregory Bristol, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2002
HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of CameroonPing Zhong, Sherri Burda, Mateusz Urbanski, et al.Journal of Virology|April 29, 2016
Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal AntibodiesBenjamin von Bredow, Juan F Arias, Lisa N Heyer, et al.The Journal of Biological Chemistry|September 15, 2005
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifsAymeric de Parseval, Michael D Bobardt, Anju Chatterji, et al.Vaccine|March 21, 2020
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticityJennifer I Lai, Susan K Eszterhas, Seth A Brooks, et al.Journal of Virology|December 17, 2010
A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infectionThomas Musich, Paul J Peters, Maria José Duenas-Decamp, et al.Journal of Virology|June 7, 2002
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesHana Golding, Marina Zaitseva, Eve de Rosny, et al.Pageof 17